Clinical Trials Browser

Interventional × sapanisertib × Other solid neoplasm × Clear all

NCT02197572 2023-01-23

Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors

Phase 1 Completed

44 enrolled 25 charts

Other solid neoplasm

Advanced Solid Tumors

NCT03430882 2022-06-21

Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors

Phase 1 Completed

Other solid neoplasm

Recurrent Malignant Solid Neoplasm